If you’re having trouble viewing this email, view it online.
The EIB - the EU bank
The EIB - the EU bank
 
July 2014     

EU and EIB Group join forces to support up to EUR 48 billion in R&I investment

In June, the EIB Group and the European Commission launched a new generation of EU financial instruments and advisory services to help innovative firms to access loan finance more easily. Over the next seven years, it is expected that the “InnovFin – EU Finance for Innovators” products will make available more than EUR 24 billion of financing for R&I by small, medium and large companies and the promoters of research infrastructures. InnovFin succeeds the RSFF/RSI programmes.

Project Highlight
"

We have to invest more. In particular, we have to invest significantly more in research and development, innovation and 21st-century-based infrastructure in order to increase our competitiveness. Today, we still can do this from a position of strength. But if we don´t face up to the challenges, we will have a very difficult time, given the global competition."

Werner Hoyer, EIB President

Author

Did you know ?

EIB investments in innovation and skills in 2013

Innovation skills

One minute, one project

Top news

France: EUR 1 billion for schools
France: EUR 1 billion for schoolsOn 23 June 2014, the EIB signed a new loan in support of energy efficiency and education – the first EUR 400 million instalment, for the refurbishment and modernisation of schools in France, of a total EIB loan of up to EUR 1 billion.
France: EUR 1 billion for schools
 
EIB Trade Finance Facility for Greece receives international award
EIB Trade Finance Facility for Greece receives international awardIn a hall full with more than 300 trade finance specialists from all over the world, the EIB received on 18th June in London, the “Deals of the Year 2013 award” by the renowned Trade Finance Magazine. The EIB Facility was selected for “providing a lifeline for Greece”.
EIB Trade Finance Facility for Greece receives international award
 
A break-through operation in the world of finance and research
A break-through operation in the world of finance and researchThe EIB has signed an agreement with the Belgian biopharmaceutical company UCB to provide “at-risk co-development funding” of up to EUR 75 million for the development of selected UCB compounds.
A break-through operation in the world of finance and research
 
More news
Your opinion matters : feedback form
Manage your subscription : unsubscribe
Contact usLinkedIn  Facebook  Twitter  Youtube
Copyright © European Investment Bank 2015